Fundraising Fox

Innovative Cardiovascular Solutions

Kalamazoo, US · Founded 2012 · Michigan LLC

Biotech

Founders & leadership

RK
Robert Kevin PlemmonsManager
SP
Shayne PlemmonsManager
WM
William MerhiManager

Reported raises · per SEC filings

Form D private placements

$7.6M disclosed across 5 rounds · 2014–2021

▶$654.6KraisedJan 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William MerhiExecutive Officer, Director
  • Shayne PlemmonsExecutive Officer, Director
  • Robert PlemmonsExecutive Officer, Director
Offering amount
$5.3M
Amount sold
$654.6K
First sale
Dec 2021
Incorporated
Limited Liability Company, Michigan
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$269.6KraisedOct 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shayne PlemmonsExecutive Officer, Director
  • Robert PlemmonsExecutive Officer, Director
  • William MerhiExecutive Officer, Director
Offering amount
$12M
Amount sold
$269.6K
First sale
Oct 2020
Incorporated
Limited Liability Company, Michigan
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$519.3KraisedSep 2018 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William MerhiExecutive Officer, Director
  • Shayne PlemmonsExecutive Officer, Director
  • Robert PlemmonsExecutive Officer, Director
Offering amount
$8M
Amount sold
$519.3K
Minimum investment
$10K
First sale
Aug 2018
Incorporated
Limited Liability Company, Michigan
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedApr 2017 · 97 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert Kevin PlemmonsExecutive Officer, Director
  • Shayne PlemmonsExecutive Officer, Director
  • William MerhiExecutive Officer, Director
Offering amount
$7M
Amount sold
$3.1M
Minimum investment
$25K
First sale
Jul 2015
Incorporated
Limited Liability Company, Michigan, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedSep 2014 · 56 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William MerhiExecutive Officer, Director
  • Robert Kevin PlemmonsExecutive Officer, Director
Offering amount
$5M
Amount sold
$3.1M
Minimum investment
$25K
First sale
Mar 2014
Incorporated
Limited Liability Company, Michigan, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Innovative Cardiovascular Solutions raised?
Innovative Cardiovascular Solutions has disclosed $7.6M raised across 5 rounds.
Where is Innovative Cardiovascular Solutions headquartered?
Innovative Cardiovascular Solutions is headquartered in Kalamazoo, US.